s6y
Company name or ticker
Search
Oncotelic Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Friday, June 4, 2010
Accession number
0000950123-10-056041
Documents
OXIGENE, INC.
POS AM
EX-23.1 CONSENT OF ERNST & YOUNG LLP.
EX-23.1
On sec.gov
Filing index
All files
Complete submission text
SGML header